Skip to main content

Table 1 The results of pathway enrichment analysis. We did pathway enrichment analysis with Partek on the genes located by the CpG markers significantly altered in KD3 vs FC or KD3 vs KD1 comparisons. Among the significant pathways (p < 0.05), four are co-enriched in the two comparisons

From: Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease

Pathway name p-value: KD3 vs FC p-value: KD3 vs KD1
Hematopoietic cell lineage 4.10E-10 7.50E-09
Cytokine-cytokine receptor interaction 2.59E-09 9.52E-12
Chemokine signaling pathway 0.00246012 2.68E-05
Jak-STAT signaling pathway 0.00287132 0.000381639